Searched for
TARO PHARMA Q3 RESULTS
MTAR Tech shares crash 9% after 280% rally in a year. What’s spooking investors today?MTAR Technologies shares fell sharply after its key client, Bloom Energy, saw its stock tumble in the US market following the suspension of...
Zee Entertainment shares rise over 3% ahead of FIFA World Cup, Rs 2,300-crore fundraising plansZee Entertainment Enterprises' shares rose after its board approved raising at least Rs 2,300 crore to fund strategic initiatives and bolst...
Betting big on mid and smallcaps; largecaps most expensive on PEG basis, says Dinshaw IraniHelios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...
Rupee to average around 96/USD in FY27; risks from oil, dollar persist: Motilal OswalThe Indian rupee is projected to average around 96 against the US dollar in FY27. However, this outlook faces potential challenges includin...
Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
Flexi-staffing industry in India sees 8% YoY growth in new employment in 2025-26: ISF reportThe push for formal employment, strongly supported by the staffing industry, has been instrumental in bringing more workers into structured...
Indian employers turn cautious for July-September quarter amid global uncertainties: ReportLooking ahead to the July-September period, India's hiring scene is poised for a slowdown as employers adopt a wait-and-see stance amidst g...
Bonus issue alert! Brigade Enterprises sets record date for 1:3 bonus share rewardBrigade Enterprises has fixed June 17 as the record date for its 1:3 bonus share issue after receiving shareholder approval through an e-vo...
Infosys dividend alert! Last date to buy IT giant's shares to secure Rs 25/sh payoutInfosys has set June 10 as the record date to determine shareholder eligibility for its final dividend of Rs 25 per share. Since shares mus...
The AI play no one is talking about: Why BofA is snapping up power & metals instead of ITBofA Securities India's Amish Shah advises shifting from IT to infrastructure, citing a 'dangerous gap' in consensus earnings forecasts. He...
India’s growth faces crude and monsoon test as FY27 GDP seen moderating to 6.5%India's economic growth is projected to slow to about 6.5 per cent in fiscal year 2027. Higher costs, global tensions and a potentially wea...
Earnings slowdown in FY27? JM Financial lists 5 sectors which must do the heavy liftingNifty 50 earnings growth fell short of expectations in FY25 and FY26. While Q4 FY26 results led to an upward revision for FY27E Nifty 50 EP...
PhysicsWallah revises lending strategy, to partner with NBFCs for student loansIn a filing on June 4, the company said it will now tie up with third-party non-banking financial companies (NBFCs) instead of lending thro...
Nagaland Lottery Sambad result out today (03-06-2026); check Rs 1 crore prize winning number and full list hereThe Nagaland State Lottery Sambad Dear Wednesday Weekly draw results for June 1, 2026, are now declared, with the ₹1 Crore first prize anno...
Q4 earnings review: Motilal Oswal highlights broad-based beat on estimates, lists 6 sectors that exceeded expectationsMotilal Oswal said Q4 FY26 earnings surpassed expectations, with aggregate profits rising 16% year-on-year against its 8% estimate. Strong ...
Buy financials, healthcare, and manufactured exports; Pramod Gubbi on investing in a tricky marketIndia's Q4 earnings show recovery signs, with Nifty 100 profits up 13%. However, macro headwinds like rising crude oil prices and a depreci...
Natco Pharma shares crash 15% after weak Q4 results; net profit tanks 34% YoYNatco Pharma shares plunged after the company reported a steep fall in fourth-quarter profit, revenue and EBITDA. Weak operating margins an...
Asian Paints Q4 Results: Net profit surges 69% YoY to Rs 1,172 crore, revenue rises 11%Asian Paints announced strong Q4 FY26 results. Net profit surged 69% to Rs 1,172 crore. Revenue from operations grew 11% to Rs 9,228.46 cro...
Sun Pharma Q4 Results: Cons profit rises 26% YoY to Rs 2,714 crore; board approves Rs 5/share dividendSun Pharma Q4 Results: Profit after tax (PAT) fell 19% sequentially during the quarter under review from Rs 3,369 crore in Q3FY26, while re...